China SXT Pharmaceuticals to consolidate shares at 1-for-100 ratio
China SXT Pharmaceuticals announced a 1-for-100 share consolidation, taking effect October 26, 2026, according to Reuters.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
China SXT Pharmaceuticals has announced a share consolidation at a ratio of 1 to 100. According to Reuters, the change will take effect on October 26, 2026.
Seeking Alpha, which published a note on the same day, included only a general disclaimer that its content is for information purposes and is not investment advice.
why it matters
A consolidation cuts the number of outstanding shares by a factor of 100, while the price of each share rises proportionally. Companies with low share prices often use such moves to support their listing, and the operation alone does not change the company's overall value.
market impact
SXT shares: the number and price of shares change after consolidation, market value is formally unchanged
tags
instruments
sources
- China SXT Pharmaceuticals announces 1-for-100 share consolidation — Seeking Alpha, 22 October 2026 at 12:16 UTC
- China Sxt Pharmaceuticals, Inc. Announces Share Consolidation — Reuters, 22 October 2026 at 13:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗